Evaluation of a ventricular assist device system: Stability in a proton beam therapy

ASAIO Journal

Volumn 58, Issue 6, 2012, Pages 597-600

  Gossman, Michael S ^a,b   Graham, Joel D ^c   Das, Indra J ^d,e   Cheng, Chee Wai ^d   Coutinho, Len ^d   Tamez, Dan ^c   Larose, Jeffrey A ^c  

^a Regulation Directive Medical Physics LLC   (United States)

^b Tri State Regional Cancer Center   (United States)

^c HEARTWARE INC   (United States)

^d INDIANA UNIVERSITY HEALTH   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HeartWare left ventricular assist device; left ventricular assist device; proton beam treatment; radiation; ventricular assist device

Indexed keywords

BASELINE VALUES; DOSE RATE; EXTERNAL COMPONENTS; HIGH ENERGY PROTON BEAMS; IMPLANTED DEVICE; PROTON BEAM THERAPY; PUMP PARAMETERS; RADIATION ONCOLOGISTS; SECONDARY NEUTRONS; SYSTEM CONTROLLERS; TREATMENT PLANS; VENTRICULAR ASSIST DEVICE;

FIBER OPTIC SENSORS; HEAT RADIATION; NEUTRON IRRADIATION; PATIENT TREATMENT; PROTON BEAMS; PUMPS; RADIATION; RADIATION DAMAGE; TISSUE;

LEFT VENTRICULAR ASSIST DEVICES;

ARTICLE; EVALUATION; HEART ASSIST DEVICE; HUMAN; PROTON THERAPY;

HEART-ASSIST DEVICES; HUMANS; PROTON THERAPY;

MLCS; MLOWN;

EID: 84868666951     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e31826feeca     Document Type: Article

References (22)

1. Rogers JG, Aaronson KD, Boyle AJ, et al: HeartMate II Investigators: Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol 55: 1826-1834, 2010.
2. Kirklin JK, Naftel DC, Kormos RL, et al: Third INTERMACS Annual Report: The evolution of destination therapy in the United States. J Heart Lung Transplant 30: 115-123, 2011.
3. Pagani FD, Miller LW, Russell SD, et al: HeartMate II Investigators: Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 54: 312-321, 2009.
4. Marbach JR, Sontag MR, Van Dyk J, Wolbarst AB: Management of radiation oncology patients with implanted cardiac pacemakers: Report of AAPM Task Group No. 34. American Association of Physicists in Medicine. Med Phys 21: 85-90, 1994.
5. Last A: Radiotherapy in patients with cardiac pacemakers. Br J Radiol 71: 4-10, 1998.
6. Mouton J, Haug R, Bridier A, Dodinot B, Eschwege F: Influence of high-energy photon beam irradiation on pacemaker operation. Phys Med Biol 47: 2879-2893, 2002.
7. Gelblum DY, Amols H: Implanted cardiac defibrillator care in radiation oncology patient population. Int J Radiat Oncol Biol Phys 73: 1525-1531, 2009.
8. Hurkmans CW, Scheepers E, Springorum BG, Uiterwaal H: Influence of radiotherapy on the latest generation of implantable cardioverter- defibrillators. Int J Radiat Oncol Biol Phys 63: 282-289, 2005.
9. Hurkmans CW, Scheepers E, Springorum BG, Uiterwaal H: Influence of radiotherapy on the latest generation of pacemakers. Radiother Oncol 76: 93-98, 2005.
10. Nitz WR, Brinker G, Diehl D, Frese G: Specific absorption rate as a poor indicator of magnetic resonance-related implant heating. Invest Radiol 40: 773-776, 2005.
11. Zaremba T, Thøgersen AM, Eschen O, Hjortshøj SP, Jakobsen AR, Riahi S: High-dose radiotherapy exposure to cardiac pacemakers may be safe in selected patients. Radiother Oncol 95: 133-134, 2010.
12. Gossman MS, Graham JD, Tamez D, Voskoboynikov N, Larose JA: Evaluation of a ventricular assist device: Stability under x-rays and therapeutic beam attenuation. ASAIO J 58: 212-216, 2012.
13. Bush DA, Slater JD, Bonnet R, et al: Proton-beam radiotherapy for early-stage lung cancer. Chest 116: 1313-1319, 1999.
14. Oshiro Y, Mizumoto M, Okumura T, et al: Results of proton beam therapy without concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer. J Thorac Oncol 7: 370-375, 2012.
15. Nichols RC, Huh SH, Hoppe BS, et al: Protons safely allow coverage of high-risk nodes for patients with regionally advanced non-small-cell lung cancer. Technol Cancer Res Treat 10: 317-322, 2011.
16. Larose JA, Tamez D, Ashenuga M, Reyes C: Design concepts and principle of operation of the HeartWare ventricular assist system. ASAIO J 56: 285-289, 2010.
17. Farr JB, Mascia AE, Hsi WC, et al: Clinical characterization of a proton beam continuous uniform scanning system with dose layer stacking. Med Phys 35: 4945-4954, 2008.
18. Andreo P, Burns DT, Hohlfeld K, et al: Absorbed dose determination in external beam radiotherapy: An international Code of Practice for dosimetry based on standards of absorbed dose to water. Vienna, Austria: IAEA Technical Report Series No. 398, 2000.
19. Wilkinson JD, Bounds C, Brown T, et al: Cancer-radiotherapy equipment as a cause of soft errors in electronic equipment. IEEE Transactions on Device and Materials Reliability 5: 449-451, 2005.
20. Gossman MS, Ketkar A, Liu AK, Olin B: Vagus nerve stimulator stability and interference on radiation oncology x-ray beams. Phys Med Biol 57: N365, 2012.
21. Hecksel D, Anferov V, Fitzek M, Shahnazi K: Influence of beam efficiency through the patient-specific collimator on secondary neutron dose equivalent in double scattering and uniform scanning modes of proton therapy. Med Phys 37(6): 2910-2917, 2010.
22. Hecksel D, Sandison GA, Farr JB, Edwards AC: Scattered neutron dose equivalent from an active scanning proton beam delivery system. Australas Phys Eng Sci Med 30(4): 326-330, 2007.